Stock analysts at UBS Group began coverage on shares of HCA Healthcare (NYSE:HCA) in a research note issued to investors on Thursday, The Fly reports. The brokerage set a “buy” rating on the stock.

A number of other equities analysts have also recently weighed in on the stock. Zacks Investment Research cut shares of HCA Healthcare from a “buy” rating to a “hold” rating in a research report on Wednesday. Argus upped their price objective on shares of HCA Healthcare from $150.00 to $155.00 and gave the stock a “buy” rating in a research report on Tuesday, November 6th. Credit Suisse Group upped their price objective on shares of HCA Healthcare from $156.00 to $165.00 and gave the stock an “outperform” rating in a research report on Thursday, November 1st. Jefferies Financial Group upped their price objective on shares of HCA Healthcare from $155.00 to $158.00 and gave the stock a “buy” rating in a research report on Wednesday, October 31st. Finally, Citigroup upped their price objective on shares of HCA Healthcare from $136.00 to $156.00 and gave the stock a “buy” rating in a research report on Thursday, October 11th. Two analysts have rated the stock with a sell rating, five have issued a hold rating and sixteen have given a buy rating to the company’s stock. The company currently has a consensus rating of “Buy” and an average price target of $141.53.

Shares of HCA traded down $2.11 during trading hours on Thursday, hitting $137.74. The stock had a trading volume of 2,628,212 shares, compared to its average volume of 1,942,892. HCA Healthcare has a fifty-two week low of $74.26 and a fifty-two week high of $144.96. The stock has a market cap of $48.84 billion, a P/E ratio of 20.90, a P/E/G ratio of 1.24 and a beta of 0.48.

HCA Healthcare (NYSE:HCA) last posted its earnings results on Tuesday, October 30th. The company reported $2.16 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.93 by $0.23. The firm had revenue of $11.45 billion during the quarter, compared to analysts’ expectations of $11.29 billion. HCA Healthcare had a net margin of 6.82% and a negative return on equity of 73.71%. The business’s revenue was up 7.1% compared to the same quarter last year. During the same period in the previous year, the business posted $1.13 EPS. Analysts forecast that HCA Healthcare will post 9.35 earnings per share for the current fiscal year.

In other news, insider Michael S. Cuffe sold 5,196 shares of the company’s stock in a transaction on Friday, November 2nd. The shares were sold at an average price of $136.52, for a total transaction of $709,357.92. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, SVP Kathryn A. Torres sold 820 shares of the company’s stock in a transaction on Tuesday, November 13th. The stock was sold at an average price of $142.36, for a total transaction of $116,735.20. The disclosure for this sale can be found here. Insiders have sold 16,763 shares of company stock valued at $2,346,147 in the last ninety days. Insiders own 2.80% of the company’s stock.

Several institutional investors have recently added to or reduced their stakes in HCA. Lee Financial Co grew its holdings in shares of HCA Healthcare by 25.9% in the third quarter. Lee Financial Co now owns 1,800 shares of the company’s stock valued at $250,000 after purchasing an additional 370 shares during the period. Kendall Capital Management grew its holdings in shares of HCA Healthcare by 5.2% in the third quarter. Kendall Capital Management now owns 8,250 shares of the company’s stock valued at $1,148,000 after purchasing an additional 405 shares during the period. Brown Advisory Inc. grew its holdings in shares of HCA Healthcare by 14.3% in the third quarter. Brown Advisory Inc. now owns 3,275 shares of the company’s stock valued at $455,000 after purchasing an additional 409 shares during the period. Smithfield Trust Co. grew its holdings in shares of HCA Healthcare by 41.2% in the third quarter. Smithfield Trust Co. now owns 1,405 shares of the company’s stock valued at $196,000 after purchasing an additional 410 shares during the period. Finally, Motley Fool Asset Management LLC grew its holdings in shares of HCA Healthcare by 12.5% in the second quarter. Motley Fool Asset Management LLC now owns 3,720 shares of the company’s stock valued at $382,000 after purchasing an additional 412 shares during the period. 70.29% of the stock is owned by institutional investors and hedge funds.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, provides health care services. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services.

Further Reading: How to Invest in a Bull Market

The Fly

Analyst Recommendations for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.